ArticleFrontiers in immunology2025

Design and immunogenicity of a quadrivalent mRNA vaccine targeting HSV-2 with comparative evaluation of co-formulated and admixed formulations.

Youngran Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.